Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.
You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTA) through any online brokerage.
Other companies in Pasithea Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and NuCana (NASDAQ:NCNA).
Pasithea Therapeutics has a consensus price target of $2.00.
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $2.65 last updated December 24, 2024 at 3:15 PM EST.
There are no upcoming dividends for Pasithea Therapeutics.
Pasithea Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Pasithea Therapeutics.
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.